We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




US Panel Supports Cloning Only for Treating Disease

By Biotechdaily staff writers
Posted on 21 May 2002
A panel of scientists from the US National Academy of Sciences (Washington, DC, USA) has reported that it supports the cloning of embryos to treat disease but not the creation of clones to reproduce human beings, which it says is not safe and should be outlawed. More...
The panel was composed of 11 experts from leading US medical and educational centers who considered the scientific and medical aspects of human reproductive cloning.

While many experts are in favor of research or therapeutic cloning, very few are in favor of reproductive cloning, so the report did not come as a surprise. However, the report adds to the ongoing US controversy over cloning. The US Senate is about to consider new legislation to ban all forms of cloning, for any purpose whatever. The legislation is backed by US President Bush. The same position is also held by the US Conference of Catholic Bishops, which argues that creating and destroying embryos for research interferes with the sanctity of human life. Meanwhile, the Council on Bioethics, appointed by President Bush, has also been wrestling with the ethics of cloning. Although no members favor reproductive cloning, many disagree on therapeutic cloning.

In recommending a ban on reproductive cloning, the academy's panel noted that within five years the ban should be reviewed, to be reconsidered only if new findings indicate that the process is safe and there is broad national backing for reconsideration. Following testimony from three scientists who plan to attempt the cloning of a human being, the panel concluded that "no voluntary system that is established to restrict reproductive cloning is likely to be completely effective.”


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.